“…We did not observe any significant effects of CaMKI or inactCaMKI infusion of mEPSC frequency (data not shown). To assess the potential involvement of CP-AMPARs in mEPSC potentiation, we used IEM-1460, a well characterized rapid and reversible inhibitor, which shows greater selectivity than philanthotoxin-433 for CPAMPARs versus GluR2-containing AMPARs and NMDARs (Magazanik et al, 1997;Buldakova et al, 1999Buldakova et al, , 2007Samoilova et al, 1999;Gray et al, 2007). For example, IEM has no effect on basal AMPA EPSCs from CA1 pyramidal neurons, which do not contain CP-AMPARs (Monyer et al, 1991;Craig et al, 1993;Geiger et al, 1995;Wenthold et al, 1996;Sans et al, 2003), whereas IEM partially suppresses AMPA EPSCs of CA1 interneurons (Buldakova et al, 2007), which do contain some CPAMPARs (Racca et al, 1996;Laezza and Dingledine, 2004).…”